Atkins J M, Pugh B R, Timewell R M
Am J Ophthalmol. 1985 Feb 15;99(2):173-5. doi: 10.1016/0002-9394(85)90227-2.
In two different medical centers, a total of 24 normal individuals (mean age, 31 years) participated in a double-masked, three-way crossover single-instillation comparison of betaxolol 1%, timolol 0.5%, and placebo. After each ocular treatment, cardiovascular characteristics were measured during ten-minute treadmill exercise periods. No significant differences in heart rate or double product (heart rate X systolic pressure) were seen between treatment with betaxolol and administration of placebo. However, when the same subjects were treated with timolol, they demonstrated significant (P less than .05) reductions in these values at various measurement times compared with placebo and betaxolol treatments. No significant differences in mean arterial pressure were detected after any of the treatments.
在两个不同的医疗中心,共有24名正常个体(平均年龄31岁)参与了一项双盲、三向交叉单剂量滴入法比较1%倍他洛尔、0.5%噻吗洛尔和安慰剂的研究。每次眼部治疗后,在十分钟的跑步机运动期间测量心血管特征。使用倍他洛尔治疗与使用安慰剂之间,心率或双乘积(心率×收缩压)未见显著差异。然而,当相同受试者使用噻吗洛尔治疗时,与安慰剂和倍他洛尔治疗相比,他们在不同测量时间的这些值均出现了显著(P<0.05)降低。任何一种治疗后均未检测到平均动脉压有显著差异。